<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD012293-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD012293-sec-0029"></div> <div class="table" id="CD012293-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="table-header separated">
<td align="left" valign="top" colspan="7" rowspan="1" class="table-header"> <p><b>Antifibrinolytic therapy compared with placebo, usual care or no intervention for preventing oral bleeding in patientson continuous oral anticoagulant treatment </b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population</b>: people on continuous oral anticoagulant treatment </p> <p><b>Settings</b>: hospitals, dental centers </p> <p><b>Intervention</b>: antifibrinolytic therapy (tranexamic acid (TXA) OR epsilon aminocaproic acid (EACA)) </p> <p><b>Comparison</b>: control (placebo, or no intervention or usual care with or without placebo) </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="" valign="" colspan="1" rowspan="2" class="table-header"> <p><b>Absolute effect</b> </p> <p><b>(RD and 95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>No. of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with control<sup>a</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with antifibrinolytic therapy</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Postoperative bleedings requiring intervention</b> </p> <p>Control group: placebo<sup>a</sup></p> <p>Followâup: 7 days</p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Study population</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RD â0.25</b> </p> <p>(â0.36 to â0.14)</p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>128<br> (2 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br> MODERATE<sup>c</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>277 per 1000</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>69 fewer per 1000</p> <p>(100 fewer to 4 fewer per 1000)</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Postoperative bleedings requiring intervention</b> </p> <p>Control group: standard Care<sup>a</sup></p> <p>Followâup: 7 days</p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Study population</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RD 0.02</b> </p> <p>(â0.07 to 0.11)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>125<br> (2 RCTs) </p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br> MODERATE<sup>c</sup></p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>630 per 10,000<sup>b</sup></p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>1 more per 10,000<sup>b</sup></p> <p>(4 fewer to 7 more per 10,000)</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Side effects or other adverse events requiring withdrawal</b> </p> <p>Control group: placebo<sup>a</sup></p> <p>Followâup: 7 days</p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Study population</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RD 0.00,</b> </p> <p>(â0.04 to 0.04)</p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>128<br> (2 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ</p> <p>MODERATE<sup>c</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>No adverse events requiring withdrawal occurred in the placebo group</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>No adverse events requiring withdrawal occurred in the antifibrinolytic therapy group</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the control group</b> is calculated at the <b>event rate</b> within the control group<b>. The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>absolute effect</b> of the intervention (and its 95% CI).<br><b>CI</b>: confidence interval; <b>RD</b>: risk difference </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High quality</b>: we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate quality</b>: we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low quality</b>: our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br><b>Very low quality</b>: we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p>a. Results for control groups (placebo and standard care) analysed separately are presented due to high levels of heterogeneity in analysis where control groups are combined (IÂ² = 80%) </p> <p>b. Risks of 'Postoperative bleedings requiring intervention' within the standard care group expressed per 10,000 due to small numbers of events occurring in both groups </p> <p>c. The evidence is downgraded once to moderate due to relatively small sample sizes (imprecision) </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
